trending Market Intelligence /marketintelligence/en/news-insights/trending/iH43jG4_nds5Cwv9SeNk7Q2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

NeuroVive raises 28.2M Swedish kronor in direct issue of shares

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

NeuroVive raises 28.2M Swedish kronor in direct issue of shares

NeuroVive Pharmaceutical AB raised 28.2 million Swedish kronor in gross proceeds from a directed new issuance of 20,897,854 shares.

Each share in the issue was priced at 1.35 Swedish kronor, a 5.1% discount to the closing price of NeuroVive's share listed on the Nasdaq Stockholm on March 6.

Proceeds from the issuance will be used to advance drug development activities.

Stockholm Corporate Finance was the financial adviser and sole book runner for the issue.

As of March 13, US$1 was equivalent to 9.31 Swedish kronor.